Breakthrough T1D is pleased insulin affordability was raised by President Biden during tonight’s State of the Union address—an issue that continues to have devastating consequences in the diabetes community. Recent progress, like the $35 monthly insulin copay cap for Medicare recipients included in the Inflation Reduction Act and voluntary price constraints implemented by pharmaceutical companies, are a step in the right direction. However, Congressional action is necessary to ensure everyone who needs insulin, regardless of insurance status, has access to this life–saving medication at an affordable price. Breakthrough T1D calls on Congress to advance the bipartisan INSULIN Act, led by Senators Jeanne Shaheen (D-NH) and Susan Collins (R-ME), which would ensure insulin is affordable for the millions of Americans who need insulin every day to survive.
March 7, 2024
